Total Payments
$533,925
2024 Payments
$20,276
Companies
58
Transactions
1,187
Medicare Patients
8,781
Medicare Billing
$690,795
Payment Breakdown by Category
Other$359,055 (67.2%)
Consulting$132,643 (24.8%)
Food & Beverage$22,000 (4.1%)
Travel$20,102 (3.8%)
Education$125.86 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $359,055 | 140 | 67.2% |
| Consulting Fee | $132,643 | 32 | 24.8% |
| Food and Beverage | $22,000 | 910 | 4.1% |
| Travel and Lodging | $20,102 | 101 | 3.8% |
| Education | $125.86 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $413,312 | 364 | $0 (2024) |
| Amgen Inc. | $56,916 | 139 | $0 (2024) |
| PFIZER INC. | $34,996 | 95 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $13,421 | 82 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $4,682 | 66 | $0 (2024) |
| Boston Scientific Corporation | $1,736 | 60 | $0 (2024) |
| ABIOMED | $1,209 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $754.45 | 47 | $0 (2024) |
| Amarin Pharma Inc. | $574.69 | 36 | $0 (2022) |
| Philips Electronics North America Corporation | $507.30 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,276 | 118 | Janssen Pharmaceuticals, Inc ($17,967) |
| 2023 | $38,063 | 129 | Janssen Pharmaceuticals, Inc ($35,775) |
| 2022 | $32,624 | 104 | Janssen Pharmaceuticals, Inc ($31,133) |
| 2021 | $61,836 | 126 | Janssen Pharmaceuticals, Inc ($53,985) |
| 2020 | $62,824 | 82 | Janssen Pharmaceuticals, Inc ($50,599) |
| 2019 | $155,549 | 253 | Janssen Pharmaceuticals, Inc ($138,913) |
| 2018 | $66,320 | 160 | Janssen Pharmaceuticals, Inc ($35,774) |
| 2017 | $96,433 | 215 | Janssen Pharmaceuticals, Inc ($49,168) |
All Payment Transactions
1,187 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Cardiovascular Diseases | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $2.05 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.13 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $26.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/14/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardiovascular Diseases | ||||||
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $71.91 | General |
| Category: Vascular | ||||||
| 09/27/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $54.03 | General |
| Category: Cardiovascular Device | ||||||
| 09/27/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.70 | General |
| Category: Cardiovascular | ||||||
| 09/25/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Genetic Disease | ||||||
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Cardiovascular | ||||||
| 09/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.65 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $126.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,359 | 3,145 | $588,350 | $180,851 |
| 2022 | 24 | 2,073 | 2,937 | $555,963 | $163,281 |
| 2021 | 29 | 2,209 | 3,208 | $554,114 | $189,154 |
| 2020 | 28 | 2,140 | 3,094 | $486,221 | $157,509 |
Total Patients
8,781
Total Services
12,384
Medicare Billing
$690,795
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 705 | 955 | $262,625 | $85,569 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 88 | 101 | $38,885 | $14,047 | 36.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 779 | 1,097 | $60,335 | $11,868 | 19.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 24 | 29 | $37,865 | $11,807 | 31.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 107 | 168 | $25,392 | $10,604 | 41.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 48 | 49 | $35,925 | $9,462 | 26.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 63 | $13,617 | $5,811 | 42.7% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 20 | 20 | $18,209 | $5,375 | 29.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $13,920 | $4,615 | 33.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 31 | $12,982 | $4,381 | 33.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 37 | $10,545 | $3,689 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $8,640 | $2,679 | 31.0% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 18 | 18 | $10,646 | $2,544 | 23.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 12 | 12 | $6,060 | $1,950 | 32.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 26 | 31 | $5,580 | $1,817 | 32.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 32 | 32 | $4,640 | $1,721 | 37.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 116 | 120 | $11,424 | $1,216 | 10.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 154 | 170 | $6,800 | $1,042 | 15.3% |
| 85610 | Blood test, clotting time | Office | 2023 | 17 | 106 | $3,180 | $445.20 | 14.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 13 | 24 | $1,080 | $208.34 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 677 | 963 | $282,285 | $88,770 | 31.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 53 | 53 | $36,920 | $11,061 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 73 | 80 | $30,080 | $11,047 | 36.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 705 | 1,002 | $73,265 | $11,000 | 15.0% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 21 | 21 | $28,375 | $9,993 | 35.2% |
About Dr. Ronald Fields, M.D
Dr. Ronald Fields, M.D is a Cardiovascular Disease healthcare provider based in New Hope, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083681548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Fields, M.D has received a total of $533,925 in payments from pharmaceutical and medical device companies, with $20,276 received in 2024. These payments were reported across 1,187 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($359,055).
As a Medicare-enrolled provider, Fields has provided services to 8,781 Medicare beneficiaries, totaling 12,384 services with total Medicare billing of $690,795. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location New Hope, PA
- Active Since 03/03/2006
- Last Updated 06/09/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1083681548
Products in Payments
- XARELTO (Drug) $413,312
- Repatha (Biological) $56,335
- ELIQUIS (Drug) $39,123
- ENTRESTO (Drug) $13,083
- Impella (Device) $1,209
- WATCHMAN (Device) $839.65
- Vascepa (Drug) $574.69
- Corlanor (Drug) $567.11
- (8324) Azurion 7 M20 (Device) $507.30
- WATCHMAN Access System (Device) $447.25
- BRILINTA (Drug) $423.13
- LEQVIO (Drug) $337.83
- DUPIXENT (Biological) $278.13
- LEXISCAN (Drug) $266.49
- VERQUVO (Drug) $252.32
- PRALUENT (Drug) $251.96
- OPTIMIZER (Device) $229.01
- Endurant (Device) $227.38
- NEXLETOL (Drug) $221.21
- CAMZYOS (Drug) $212.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.